Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. antigen production
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Antigen Production Articles & Analysis

13 news found

Creative BioMart Enhances Epitope Mapping Services to Support Antibody and Vaccine Development

Creative BioMart Enhances Epitope Mapping Services to Support Antibody and Vaccine Development

The platform covers both linear and conformational epitope analysis and includes the following core services: l Binding Activity Confirmation: ELISA or Western blot assays to verify the interaction between the submitted antibody and antigen. l Glycosylation Analysis (Optional): Comparing antibody binding to glycosylated versus deglycosylated forms of the ...

ByCreative BioMart


H5N1 Antibodies and Antigens for Research Applications

H5N1 Antibodies and Antigens for Research Applications

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, is excited to announce the launch of its new line of H5N1 Antibodies and Antigens to support cutting-edge research on this highly pathogenic influenza A virus subtype. These innovative products offer researchers and scientists invaluable tools for ...

ByCreative Diagnostics


CEPI’s $3.6B Initiative with ExcellGene: Single Molecule for Global Defense in COVID Trials

CEPI’s $3.6B Initiative with ExcellGene: Single Molecule for Global Defense in COVID Trials

In fact, ExcellGene demonstrated that a single 40 L bioreactor based production run can provide antigens in sufficient quantity to immunize about 5 million people, i.e. half of the Swiss population. Most promising data were shared on an ExcellGene patented principle for generating chimaeric antigens. In this case, the Corona protein was initially ...

ByExcellGene SA


(Viral) Vaccine Manufacturing

(Viral) Vaccine Manufacturing

Viral vaccine manufacturing is a complex venture with the main steps being antigen production, purification and formulation. It takes between 8 to 36 months to produce, package and deliver vaccines to those who need them. ...

ByNuvonis


Creative Diagnostics Introduces New Nipah Virus Antigens and Antibodies

Creative Diagnostics Introduces New Nipah Virus Antigens and Antibodies

As a global leading supplier of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics recently launches a series of NiV recombinant antigen and antibody pairs. All of these new products are produced using standardized production processes to ensure the highest quality. ...

ByCreative Diagnostics


Amerigo Scientific Introduces the Launch of Polystreptavidin 350

Amerigo Scientific Introduces the Launch of Polystreptavidin 350

Amerigo Scientific partners with global diagnostic manufacturers to provide a broad, broad portfolio of clinical diagnostics products to simplify workflows and improve operational efficiency. The product portfolio includes FDA or CE approved in vitro diagnostic kits, basic biological raw materials, and automated instruments and reagents for clinical chemistry, ...

ByAmerigo Scientific


Creative Diagnostics Launches Staphylococcal Enterotoxin Antigens

Creative Diagnostics Launches Staphylococcal Enterotoxin Antigens

The newly introduced antigens consist of five of the most common staphylococcus aureus enterotoxins and are ideal for in vitro detection and diagnostic studies. ...

ByCreative Diagnostics


Fate Therapeutics Announces FDA Clearance for FT536, a First-in-class MICA/B-targeted CAR NK Cell Product Candidate for the Treatment of Solid Tumors

Fate Therapeutics Announces FDA Clearance for FT536, a First-in-class MICA/B-targeted CAR NK Cell Product Candidate for the Treatment of Solid Tumors

Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for FT536, an off-the-shelf, multiplexed-engineered, iPSC-derived, chimeric antigen receptor (CAR) NK cell product candidate. FT536 is derived from a clonal master induced pluripotent stem cell (iPSC) line engineered with four functional elements, ...

ByFate Therapeutics, Inc.


Lixte Biotechnology’s LB-100 Reported to Convert Immunologically Unresponsive (“Cold”) Tumors to Immunologically Responsive (“Hot”) Tumors

Lixte Biotechnology’s LB-100 Reported to Convert Immunologically Unresponsive (“Cold”) Tumors to Immunologically Responsive (“Hot”) Tumors

In Nature Communications (15 Dec 2021), lead author Yu-Ting Yen and colleagues at the China Medical University and Hospital, Taichung, Taiwan reported that treatment with LB-100 is associated with new antigen production, tumor infiltration of cytotoxic T cells, and enhanced responsiveness to immune checkpoint blockade in mouse models of colorectal, ...

ByLIXTE Biotechnology Holdings, Inc.


Quidel’s Antigen Tests Detect the Omicron Variant

Quidel’s Antigen Tests Detect the Omicron Variant

Recent testing using live South African samples confirmed that our QuickVue® At-Home OTC COVID-19 Test and our Sofia® SARS Antigen FIA are detecting the SARS-CoV-2 Omicron variant. On December 22, 2021, the Food and Drug Administration (FDA) indicated that data generated in preliminary RADx laboratory studies, with heat-inactivated Omicron samples, suggested that the ...

ByQuidel Corporation


Patent of new vaccine platform from Abera Bioscience receives notice of allowance from US patent office

Patent of new vaccine platform from Abera Bioscience receives notice of allowance from US patent office

It entails technology that allows the efficient production of disease-specific antigens in so-called protein bodies, nanosized protein particles that can be administered to the body as vaccines. ...

ByAbera Bioscience AB


Vaccines for Infectious Diseases: How Do They Work?

Vaccines for Infectious Diseases: How Do They Work?

The goal of any vaccine is to generate immunity to pathogens, in order to reduce the spread of infectious diseases. A vaccine antigen (a foreign substance, usually a protein, that induces an immune response) is introduced into the body (most often via an injection), with the intention of stimulating the production of antibodies helpful in fighting off future ...

ByEnGen Bio LLC


Dengue Virus-Like Particles launched

Dengue Virus-Like Particles launched

The Native Antigen Company Limited (‘NAC’: Oxford, UK) announces the launch of a new range of Dengue Virus-Like Particles incorporating products for all four Dengue serotypes. ...

ByThe Native Antigen Company

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT